Understanding Hydronephrosis Occurrence by an Individual-Kidney Level Analysis of all Events Postchemoradiation Therapy for Locally Advanced Cervical Cancer
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2025.04.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Lucas Gomes Sapienza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas; Department of Radiation Oncology, University of Florida College of Medi…. Hauptthemen laut MEDLINE: Hydronephrosis, Uterine Cervical Neoplasms, Chemoradiotherapy, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Hydronephrosis is a complex renal abnormality that requires assessment of individual-kidney status at different times for correct interpretation of the mechanism of damage. This study analyzes all hydronephrosis events in women with locally advanced cervical cancer. METHODS AND MATERIALS: The status of 449 kidneys from 225 women treated with external beam radiation therapy (RT) with concurrent cisplatin and image guided adaptive brachytherapy were retrospectively reviewed. Hydronephrosis incidence, causes (including radiation-induced hydronephrosis [RIH]), associated factors, and resolution rates were analyzed. Univariable and multivariable analyses were performed at the individual-kidney level, clustered by individual patient. RESULTS: At baseline, 10.9% (49/449) of the kidneys were affected by hydronephrosis, which resolved in 38.8% (19/49) after RT. During follow-up, new hydronephrosis occurred in 15.8% (71/419) of the kidneys, caused more frequently by cancer recurrence than by RIH (2:1 ratio). The overall RIH incidence per kidney was 5.7% (95% CI, 3.2-8.1) and 7.2% (95% CI, 3.8-10.4) at 3 and 5 years, respectively. The rates of type A RIH (ureteral stenosis) at 3 and 5 years were 1.9% (95% CI, 0.5-3.3) and 3.5% (95% CI, 0.8-6.2). Both 3- and 5-year rates of type B RIH (damage to structures other than ureter) were 3.8% (95% CI, 1.7-5.9). Point A dose (P = .01; EQD23), bladder D2.0cc (P = .03; EQD23), and high-risk clinical target volume (P < .01; cm3) were associated with overall hydronephrosis incidence in the multivariable model. Point A dose was associated with type A RIH (P < .01) but not with type B (P = .74). At last follow-up, 19.6% (88/449) of kidneys had unresolved hydronephrosis. CONCLUSIONS: Persistent hydronephrosis is not uncommon after definitive RT for locally advanced cervical cancer (20%), with RIH being a relevant etiology at 5 years (7%). In contrary to type B RIH (damage to other structures), type A (ureteral damage) is usually unilateral, associated with dose to the ipsilateral point A, and its incidence does not plateau over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas; Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida. Electronic address: lucasgsapienza@gmail.…
- Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas.
- School of Medicine, Baylor College of Medicine, Houston, Texas.
- Department of Biostatistics and Bioinformatics, Cedars-Sinai Medical Center, Los Angeles, California.
- Department of Radiation Oncology, Hospital Federal dos Servidores do Estado (HFSE-RJ), Rio de Janeiro, Brazil.
- Department of Urology, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Zitieren
APA
Sapienza, L. G., Chapman, C. H., Jhavar, S., Calsavara, V. F., Ludwig, M. S., Gomes, M. J. L., & Carvalho, E. F. (2025). Understanding Hydronephrosis Occurrence by an Individual-Kidney Level Analysis of all Events Postchemoradiation Therapy for Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.04.033
Vancouver
Sapienza LG, Chapman CH, Jhavar S, Calsavara VF, Ludwig MS, Gomes MJL, et al. Understanding Hydronephrosis Occurrence by an Individual-Kidney Level Analysis of all Events Postchemoradiation Therapy for Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.04.033
BibTeX
@article{Sapienza2025,
author = {Sapienza, Lucas Gomes and Chapman, Christina Hunter and Jhavar, Samyukta and Calsavara, Vinícius Fernando and Ludwig, Michelle Suzanne and Gomes, Maria José Leite and Carvalho, Emanuel de Freitas},
title = {Understanding Hydronephrosis Occurrence by an Individual-Kidney Level Analysis of all Events Postchemoradiation Therapy for Locally Advanced Cervical Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2025.04.033}
}
EUVIMED